April 2008

Research on characteristics of the biopharmaceutical pipeline and on changes since 2003 includes a description of new features and recommendations for health policy decision makers.

Asthma-specific quality of life and a history of acute episodes can be used together to identify risks of subsequent acute exacerbations.

Evidence to support the introduction of shared care services into clinical practice is limited, although methodologic shortcomings may account for this lack of evidence.

Among young, sexually active women, self-reported Chlamydia trachomatis screening rates were primarily influenced by risk factors rather than insurance coverage.

A panel composed of medical and pharmacy directors expressed strong support for a greater role for cost-effectiveness analysis in US health policy decisions.

Compared with other costs of treatment, expenditures for antibiotics were nominal in an adult primary care population with lower respiratory tract infections.